Interview: Data acquisition, tumor heterogeneity and precision medicine: Future challenges for oncologic comparative effectiveness research

Al B Benson III*

*Corresponding author for this work

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Al B Benson 3rd, MD, FACP, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine in Chicago (IL, USA). He is also the Associate Director for Clinical Investigations for the Robert H Lurie Comprehensive Cancer Center. Benson earned his medical degree at the State University of New York at Buffalo, following which he completed an Internal Medicine Residency at the University of Wisconsin Hospitals in Madison (WI, USA). He was an Assistant Professor of Medicine at the University of Illinois and Co-Medical Director for the National Public Health Service in Champaign (IL, USA). He then served as a Clinical Oncology Fellow at the University of Wisconsin Clinical Cancer Center. Benson is a recipient of the American Society of Clinical Oncology (ASCO) Statesman Award (Fellow of ASCO). He has been a member of the ASCO Task Force on Quality of Cancer Care, the Co-Chair of ASCO's Stage II Colon Cancer Guidelines Panel and the Guidelines Panel for use of Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases. He also is the Chair of both the Eastern Cooperative Oncology Group Gastrointestinal and Data Monitoring Committees. In addition, he is a past President of the Illinois Medical Oncology Society, past President for the Association of Community Cancer Centers, and a member of the Executive Committee and immediate past-chair of the Board of Directors of the National Comprehensive Cancer Network (NCCN). He is a member of the Board of the NCCN Foundation and ECOG Research and Education Foundation. He is the past President of the International Society of GI Oncology. Benson is a member of the Scientific Board of Directors of the Patient Advocate Foundation, the National Patient Advocate Foundation, Fight Colorectal Cancer and Friends of Cancer Research. Benson's research is primarily in the areas of gastrointestinal cancer clinical trials and cancer guideline development. Benson is an associate editor of the Journal of Comparative Effectiveness Research.

Original languageEnglish (US)
Pages (from-to)17-21
Number of pages5
JournalJournal of Comparative Effectiveness Research
Volume2
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Comparative Effectiveness Research
Precision Medicine
Interviews
Medical Oncology
Neoplasms
Medicine
Guidelines
Colorectal Neoplasms
Clinical Trials Data Monitoring Committees
Research
Committee Membership
Physician Executives
Gastrointestinal Neoplasms
United States Public Health Service
Quality of Health Care
Medical Societies
Buffaloes
National Health Programs
Hematology
Advisory Committees

ASJC Scopus subject areas

  • Health Policy

Cite this

@article{e0a13b79880a4b459a042b57ecb9fe93,
title = "Interview: Data acquisition, tumor heterogeneity and precision medicine: Future challenges for oncologic comparative effectiveness research",
abstract = "Al B Benson 3rd, MD, FACP, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine in Chicago (IL, USA). He is also the Associate Director for Clinical Investigations for the Robert H Lurie Comprehensive Cancer Center. Benson earned his medical degree at the State University of New York at Buffalo, following which he completed an Internal Medicine Residency at the University of Wisconsin Hospitals in Madison (WI, USA). He was an Assistant Professor of Medicine at the University of Illinois and Co-Medical Director for the National Public Health Service in Champaign (IL, USA). He then served as a Clinical Oncology Fellow at the University of Wisconsin Clinical Cancer Center. Benson is a recipient of the American Society of Clinical Oncology (ASCO) Statesman Award (Fellow of ASCO). He has been a member of the ASCO Task Force on Quality of Cancer Care, the Co-Chair of ASCO's Stage II Colon Cancer Guidelines Panel and the Guidelines Panel for use of Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases. He also is the Chair of both the Eastern Cooperative Oncology Group Gastrointestinal and Data Monitoring Committees. In addition, he is a past President of the Illinois Medical Oncology Society, past President for the Association of Community Cancer Centers, and a member of the Executive Committee and immediate past-chair of the Board of Directors of the National Comprehensive Cancer Network (NCCN). He is a member of the Board of the NCCN Foundation and ECOG Research and Education Foundation. He is the past President of the International Society of GI Oncology. Benson is a member of the Scientific Board of Directors of the Patient Advocate Foundation, the National Patient Advocate Foundation, Fight Colorectal Cancer and Friends of Cancer Research. Benson's research is primarily in the areas of gastrointestinal cancer clinical trials and cancer guideline development. Benson is an associate editor of the Journal of Comparative Effectiveness Research.",
author = "{Benson III}, {Al B}",
year = "2013",
month = "1",
day = "1",
doi = "10.2217/cer.12.76",
language = "English (US)",
volume = "2",
pages = "17--21",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Interview

T2 - Data acquisition, tumor heterogeneity and precision medicine: Future challenges for oncologic comparative effectiveness research

AU - Benson III, Al B

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Al B Benson 3rd, MD, FACP, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine in Chicago (IL, USA). He is also the Associate Director for Clinical Investigations for the Robert H Lurie Comprehensive Cancer Center. Benson earned his medical degree at the State University of New York at Buffalo, following which he completed an Internal Medicine Residency at the University of Wisconsin Hospitals in Madison (WI, USA). He was an Assistant Professor of Medicine at the University of Illinois and Co-Medical Director for the National Public Health Service in Champaign (IL, USA). He then served as a Clinical Oncology Fellow at the University of Wisconsin Clinical Cancer Center. Benson is a recipient of the American Society of Clinical Oncology (ASCO) Statesman Award (Fellow of ASCO). He has been a member of the ASCO Task Force on Quality of Cancer Care, the Co-Chair of ASCO's Stage II Colon Cancer Guidelines Panel and the Guidelines Panel for use of Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases. He also is the Chair of both the Eastern Cooperative Oncology Group Gastrointestinal and Data Monitoring Committees. In addition, he is a past President of the Illinois Medical Oncology Society, past President for the Association of Community Cancer Centers, and a member of the Executive Committee and immediate past-chair of the Board of Directors of the National Comprehensive Cancer Network (NCCN). He is a member of the Board of the NCCN Foundation and ECOG Research and Education Foundation. He is the past President of the International Society of GI Oncology. Benson is a member of the Scientific Board of Directors of the Patient Advocate Foundation, the National Patient Advocate Foundation, Fight Colorectal Cancer and Friends of Cancer Research. Benson's research is primarily in the areas of gastrointestinal cancer clinical trials and cancer guideline development. Benson is an associate editor of the Journal of Comparative Effectiveness Research.

AB - Al B Benson 3rd, MD, FACP, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine in Chicago (IL, USA). He is also the Associate Director for Clinical Investigations for the Robert H Lurie Comprehensive Cancer Center. Benson earned his medical degree at the State University of New York at Buffalo, following which he completed an Internal Medicine Residency at the University of Wisconsin Hospitals in Madison (WI, USA). He was an Assistant Professor of Medicine at the University of Illinois and Co-Medical Director for the National Public Health Service in Champaign (IL, USA). He then served as a Clinical Oncology Fellow at the University of Wisconsin Clinical Cancer Center. Benson is a recipient of the American Society of Clinical Oncology (ASCO) Statesman Award (Fellow of ASCO). He has been a member of the ASCO Task Force on Quality of Cancer Care, the Co-Chair of ASCO's Stage II Colon Cancer Guidelines Panel and the Guidelines Panel for use of Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases. He also is the Chair of both the Eastern Cooperative Oncology Group Gastrointestinal and Data Monitoring Committees. In addition, he is a past President of the Illinois Medical Oncology Society, past President for the Association of Community Cancer Centers, and a member of the Executive Committee and immediate past-chair of the Board of Directors of the National Comprehensive Cancer Network (NCCN). He is a member of the Board of the NCCN Foundation and ECOG Research and Education Foundation. He is the past President of the International Society of GI Oncology. Benson is a member of the Scientific Board of Directors of the Patient Advocate Foundation, the National Patient Advocate Foundation, Fight Colorectal Cancer and Friends of Cancer Research. Benson's research is primarily in the areas of gastrointestinal cancer clinical trials and cancer guideline development. Benson is an associate editor of the Journal of Comparative Effectiveness Research.

UR - http://www.scopus.com/inward/record.url?scp=84886943367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886943367&partnerID=8YFLogxK

U2 - 10.2217/cer.12.76

DO - 10.2217/cer.12.76

M3 - Review article

C2 - 24236518

AN - SCOPUS:84886943367

VL - 2

SP - 17

EP - 21

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6305

IS - 1

ER -